BioCryst Pharmaceuticals Shares Up 24.6% Since SmarTrend's Buy Recommendation (BCRX)
March 31, 2017 at 01:57 AM EDT
SmarTrend identified an Uptrend for BioCryst Pharmaceuticals (NASDAQ:BCRX) on March 1st, 2017 at $6.68. In approximately 4 weeks, BioCryst Pharmaceuticals has returned 24.64% as of today's recent price of...
